First-pass denial rate is the share of claims denied on their first submission, before any appeal or correction. It is a useful measure of how clean your front end is: eligibility checks, authorization, coding accuracy, and payer rule compliance.

What it does not tell you is how much revenue is actually lost. Most initially denied claims are fixable and get paid after rework. The number that matters for your bottom line is the final denial rate: the share of expected revenue written off after all appeals. A practice can have a high initial denial rate and a low final one if its follow-up is excellent, though that follow-up is expensive labor either way.

The most quoted dataset in trade press comes from Kodiak Solutions, reporting an initial denial rate of about 11.8 percent. It gets cited constantly because it is one of the few figures attached to a named analytics firm and a real dataset.

Alongside it, a crowd of vendor blogs and service pages cite 5 to 10 percent, often without naming a source at all. These two figures appear on the same search results pages contradicting each other, which tells you everything about the state of this data. Neither figure is independently audited, and both are old enough that payer behavior has shifted since they were measured.

The gap is mostly definitional. Studies differ on whether they count initial denials or final write-offs, whether the denominator is all claims or only clean claims, which specialties and payer mixes are in the sample, and what year the data comes from. A 5 percent final write-off rate and an 11.8 percent initial denial rate can describe the same revenue cycle.

Sample composition matters too. A dataset heavy on hospital claims will look worse than one heavy on office visits. A dataset from before a major payer policy change will not match one from after. When a vendor quotes you a benchmark without its definition, sample, and year, the number is decoration.

In general terms, aim for a low single-digit final denial rate after appeals, and treat your initial denial rate as a diagnostic rather than a grade. The right target depends on your specialty, payer mix, and how much of your volume needs prior authorization.

The most useful benchmark is your own trend. Track initial denials by reason code and by payer every month, and fix the top two causes. A practice that cuts its initial denial rate by a third through front-end fixes will feel it in cash flow faster than one chasing someone else's published number.

When you evaluate a vendor, ask how they measure denials and what they report to you. Good answers include denial reason tracking, appeal turnaround, and a monthly review of the top denial causes with corrective actions. Weak answers quote a benchmark and change the subject.

Also ask what share of denials they consider preventable versus payer-driven. A vendor that blames payers for everything is telling you they have no front-end process. A vendor that shows you their denial workflow, their escalation rules, and their results for practices like yours is worth a deeper conversation.